| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.095 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |